Pharma.Aero announces four new additions to its global community of Life Sciences end-to-end supply chain stakeholders: Saudia Cargo, SAL Saudi Logistics and Hellmann sign up as members; VEXSL and QProducts & Services join as associate partners.
Mark van Os de Man, the Global Airfreight Product Director for Healthcare at Hellmann, recognizes the significance of collaboration within the healthcare supply chain for achieving continuous improvement: “We believe that becoming a part of industry interest groups such as Pharma.Aero offers a valuable platform to engage with all stakeholders and facilitate positive changes in the healthcare and life science industry. Hellmann aims to leverage their expertise, track record, and forward-thinking approach to become a significant contributor to the Pharma.Aero community.”
Trevor Caswell, Chairman of Pharma.Aero, extends a warm greeting to the new members and associate partners representing diverse industry segments, stating, "We are thrilled to welcome such a diverse group of supply chain stakeholders to our global community. We look forward to collaborating and leveraging their expertise in addressing the industry's challenges and enhancing end-to-end chain visibility for life science and MedTech products."
Cole Fouillard, CEO of VEXSL, emphasizes the company’s enthusiasm for this partnership. “We at VEXSL are excited to join Pharma.Aero in the pursuit of aligning with some of the top pharmaceutical logistics companies in the world. As a growing company, we welcome the opportunity to learn, adopt and apply the cutting-edge technologies, procedures and strategies through the collaboration of fellow associate members, partners and board members of Pharma.Aero. Our mission is to provide a safe and secure shipping solution for our customers that assures the care and custody of the products shipped while purposefully employing military veterans and first responders in the process. We couldn’t think of a more willing organization, with such a purpose driven mission than Pharma.Aero and we look forward to the future of pharma logistics.”